Proteinuria at five years after kidney transplantation: the role of anti-HCV-positive state.
Virgilio
B
B
Treviso Transplant Centre, Treviso General Hospital, Treviso, Italy.
Palminteri
G
G
Maresca
M C
MC
Brunello
A
A
Calconi
G
G
Vianello
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D016174:Hepacivirus / Q000302:isolation & purification*; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D015995:Prevalence; D011507:Proteinuria / Q000503:physiopathology*; D012044:Regression Analysis; D012189:Retrospective Studies; D012254:Ribavirin / Q000627:therapeutic use; D013997:Time Factors
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D012254:Ribavirin